Related Experiment Videos
Recombinant live Salmonella spp. for human vaccination against heterologous pathogens
D Bumann1, C Hueck, T Aebischer
1Max-Planck-Institut für Infektionsbiologie, Abt. Molekulare Biologie, Monbijoustrasse 2, D-10117, Berlin, Germany.
FEMS Immunology and Medical Microbiology
|March 23, 2000
Abstract:
Live attenuated Salmonella spp. are promising candidates as oral vaccine delivery systems for heterologous antigens. Clinical trials have demonstrated that this approach is feasible for human vaccinations but further optimisation is necessary to obtain a better efficacy. Here, we discuss how existing clinical and pre-clinical data can be used to guide such optimisation efforts.